Reversal of multifocal cutaneous lymphoproliferative disease associated with Epstein-Barr virus after withdrawal of methotrexate therapy for rheumatoid arthritis.

[1]  S. Fischer,et al.  Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas. , 2004, Journal of the National Cancer Institute.

[2]  H. Heslop,et al.  Cellular therapy of Epstein-Barr-virus-associated post-transplant lymphoproliferative disease. , 2004, Best practice & research. Clinical haematology.

[3]  D. Porter,et al.  Post-transplant lymphoproliferative disorder: a review , 2003, Bone Marrow Transplantation.

[4]  P. Gaulard,et al.  Epstein–Barr virus‐associated lymphoproliferative disease occurring in a patient with sarcoidosis treated by methotrexate and methylprednisolone , 2002, European journal of haematology.

[5]  J. V. van Krieken,et al.  Initial spontaneous remission of posttransplantation Epstein Barr virus-related B-cell lymphoproliferative disorder of the skin in a renal transplant recipient: case report and review of the literature on cutaneous B-cell posttransplantation lymphoproliferative disease. , 2002, The American Journal of dermatopathology.

[6]  P. Souteyrand,et al.  Cutaneous lymphoma associated with Epstein-Barr virus infection in 2 patients treated with methotrexate. , 2001, Mayo Clinic proceedings.

[7]  P. Gaulard,et al.  Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with clonal lymphoproliferative disorders after orthotopic liver transplantation: a report of three cases. , 2000, Journal of hepatology.

[8]  M. van de Rijn,et al.  A population based, case control study of non-Hodgkin's lymphoma in patients with rheumatoid arthritis. , 1999, The Journal of rheumatology.

[9]  J. Cayuela,et al.  Epstein-Barr virus-associated lymphoproliferative disease during methotrexate therapy for psoriasis. , 1997, Archives of dermatology.

[10]  M. van de Rijn,et al.  Clonality of Epstein-Barr virus in lymphoproliferative disorders in patients treated with immunosuppressive therapy for rheumatoid arthritis. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  J. Lacy,et al.  Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  H. Dombret,et al.  Methotrexate related B lymphoproliferative disease in a patient with rheumatoid arthritis. Role of Epstein-Barr virus infection. , 1995, The Journal of rheumatology.

[13]  R. Warnke,et al.  Lymphoid neoplasms in patients with rheumatoid arthritis and dermatomyositis: frequency of Epstein-Barr virus and other features associated with immunosuppression. , 1994, Human pathology.

[14]  R. Warnke,et al.  Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis. , 1993, The New England journal of medicine.

[15]  J. Locker,et al.  The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. , 1988, The American journal of pathology.